Christopher DeWolf becomes chair of the board for CHPA
NAPLES, Fla. Members of the Consumer Healthcare Products Association on Saturday elected Christopher DeWolf, president and CEO of Lil’ Drug Store Products, to the top leadership role within the association.
“CHPA is truly fortunate to have such a long history of competent and creative board of director chairs,” stated Linda Suydam, CHPA president. “Chris is just such an individual, and the association and the over-the-counter medicine and nutritional supplement industries we serve are privileged to have him at the helm, especially during these challenging times.”
DeWolf becomes CHPA’s 53rd chair of the board and succeeds John Hendrickson of Perrigo. DeWolf was first elected to the CHPA board in 2007 and has held the posts of both vice chair and chair of the association’s Business Development Committee.
CV Therapeutics’ board of directors rejects Astellas’ tender offer
PALO ALTO, Calif. The board of directors of CV Therapeutics announced Friday it has rejected Astellas’ tender offer of $16 per share.
CV Therapeutics’ determined that the offer “undervalues the company and is not in the best interests of its stockholders”, according to a release.
The announcement comes once day after Gilead Sciences announced it would acquire CV Therapeutics, making it a wholly owned subsidiary of Gilead. The transaction is valued at approximately $1.4 billion, with a tender offer of $20 per share.
Take Care Health Systems opens new clinic in Phoenix
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened a new clinic in the Phoenix market, the clinic operator announced on Friday.
With the new opening, the company now has 18 clinics in that market.
Take Care Health Systems operates a total of 339 clinics in 35 markets throughout 19 states.